Schools must adapt to extreme heat in a warming world
Reports and Proceedings
Updates every hour. Last Updated: 26-Oct-2026 01:15 ET (26-Oct-2026 05:15 GMT/UTC)
Heat waves pose a growing threat to learning, health and well-being in schools as extreme heat becomes more frequent and intense across the United States, finds a report by the American Psychological Association and the Network for Resilient PK-12 Schools.
Habitual cannabis users experienced about 9% fewer premature heartbeats on days they inhaled cannabis compared with days they abstained, a counterintuitive finding that adds to the complex and evolving understanding of how cannabis affects the heart, new UC San Francisco-led research found.
Generative AI gives health experts the ability to create realistic synthetic genetic data that helps to identify behaviour of disease complications.
Researchers have found that pediatric-onset rheumatic and inflammatory diseases have distinct genetic architecture compared with adults. The findings could pave the way for the discoveries that have benefitted adult patients with similar conditions, like better disease classification and the development of precision therapies.
What if one of the keys to a healthier metabolism is understanding how and when the liver communicates with the rest of the body?
Researchers at UT Health San Antonio, the academic health center of The University of Texas at San Antonio (UT San Antonio), have uncovered how the liver’s internal clock coordinates the release of proteins that help regulate metabolism.
New research finds that men who consume higher amounts of ultra-processed foods (UPFs) have significantly greater risks of prostate cancer. Analyzing nationally representative data from 17,024 U.S. men, researchers found a 29% higher risk among those in the three highest UPF-consumption groups and a 30% higher risk among those in the two highest groups. After adjusting for key factors, elevated risk remained significant, ranging from 24% to 31%.
A Case Western Reserve University–led research team is developing a noninvasive oral cancer test to help clinicians decide—chairside and within minutes— whether a suspicious lesion in the mouth needs a biopsy.
CAMBRIDGE, Mass., Aug 12 — Insilico Medicine (“Insilico”; HKEX: 3696), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, today announced the nomination of ISM0900, a potent, AI-driven, highly selective, orally available small molecule inhibitor of lipoprotein(a), or Lp(a), as a preclinical candidate (PCC) for the management of cardiovascular risks. Notably, this marks the company's 9th PCC nomination announced since 2026, showcasing the enhanced efficiency and scalability that generative AI brings to early-stage drug discovery.